Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youlong Hai

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Materials Today. Bio|December 17, 2025
Nanoparticle-based drug delivery systems in urologic oncology: From targeted therapy to precision theranosticsJiayi Ma, Youlong Hai, Kun Zheng, et al.
Journal of Translational Medicine|April 17, 2024
Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction modelKun Zheng, Youlong Hai, Hongqi Chen, et al.
Pharmaceutics|February 27, 2026
Harnessing Folate-Mediated PSMA Targeting for Precision Therapy: An Intelligent Liposomal Nanoplatform Against Prostate CancerYoulong Hai, Jiayi Ma, Xuehao Yu, et al.
Journal of Translational Medicine|November 8, 2023
Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significanceKun Zheng, Youlong Hai, Yue Xi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2024
Tamsulosin ameliorates bone loss by inhibiting the release of Cl<sup>-</sup> through wedging into an allosteric site of TMEM16AShiliang Li, Weijia Sun, Shuang Li, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Materials Today. Bio|December 17, 2025
Nanoparticle-based drug delivery systems in urologic oncology: From targeted therapy to precision theranosticsJiayi Ma, Youlong Hai, Kun Zheng, et al.
Journal of Translational Medicine|April 17, 2024
Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction modelKun Zheng, Youlong Hai, Hongqi Chen, et al.
Pharmaceutics|February 27, 2026
Harnessing Folate-Mediated PSMA Targeting for Precision Therapy: An Intelligent Liposomal Nanoplatform Against Prostate CancerYoulong Hai, Jiayi Ma, Xuehao Yu, et al.
Journal of Translational Medicine|November 8, 2023
Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significanceKun Zheng, Youlong Hai, Yue Xi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2024
Tamsulosin ameliorates bone loss by inhibiting the release of Cl<sup>-</sup> through wedging into an allosteric site of TMEM16AShiliang Li, Weijia Sun, Shuang Li, et al.
Pageof 1